| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Highly potent synthetic glucocorticoid that suppresses acute and chronic inflammmation; potentiates vascular smooth muscle relaxation by beta-adrenergic agonists. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute spinal cord trauma, anaphylaxis, broncodilator for unresponsive asthma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Premature infants, systemic fungal infections, use with caution in patients with gastrointestinal bleeding. |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions/side effects |  | Definition 
 
        | Depression, euphoria, headache, restlessness, seizure, increased ICP, pulmonary tuberculosis, hypertension, CHF, nausea, vomiting, peptic ulcer, fluid retention, hypernatremia, hyperkalemia. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypoglycemic responses to insulin and hypoglycemic agents may be blunted. |  | 
        |  | 
        
        | Term 
 
        | Dosage and administration  Adult |  | Definition 
 
        | Acute spinal cord trauma; 30 mg/kg IV over 30 minutes followed by:  Infusion: 5.4 mg/kg/h.  Asthma, COPD, anaphylaxis: 1-2 mg/kg IV. |  | 
        |  | 
        
        | Term 
 
        | Dosage and administration  Pediatrics |  | Definition 
 
        | Acute spinal cord trauma: Same as adult.  Status asthmaticus/anaphylaxis: 2 mg/kg/dose IV/IO/IM to a maximum dose of 60 mg. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Onset: 1-5 minutes Peak effect: variable Duration: 6-8 hours.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pregnancy Safety: Category C.  Not effective if time of spinal cord injury greater than 8 hours.  Crosses the placenta and may cause fetal harm. |  | 
        |  |